baber/WOPTO huggingface dataset:
Patent FI-823975-A0 (FI)
Inventor: BECHGAARD HELLE
IPC: A61K9/22
Filed: 1982-11-19
Abstract: A pharmaceutical oral controlled release multiple-units formulation in which individual units comprise cross-sectionally substantially homogeneous cores containing particles of a sparingly soluble active substance, the cores being coated with a coating which is substantially resistant to gastric conditions, but which is erodable under the conditions prevailing in the small intestine, in particular an enteric coating which is substantially insoluble at a pH below 7 such as Eudragit<sup>0</sup> S (an anionic polymerisate of methacrylic acid and methacrylic acid methyl ester), is prepared by a process comprising comminuting an active substance together with a substance which is readily soluble in intestinal fluids such as an anionic detergent to obtain particles containing the active substance in intimate admixture with the readily soluble substance, combining the resulting particles into cross-sectionally substantially homogeneous cores together with components which accelerate the disintegration of the cores in intestinal fluids such as talc and sucrose, coating the individual cores with the coating, and combining a multiplicity of the coated cores into a capsule or tablet formulation.As the coating is erodable in an alkaline environment only, the active substance is not released until the units arrive at a section ofthe small intestine with an alkaline pH. Thus, a reduction and delay of the peak plasma concentration is obtained without affecting the extent of drug availability.A coating of the above-defined type may also be used when the active substance is a substance which exerts an irritating effect on the gastric mucosa and/or is unstable in an acidic environment.
Patent FI-853567-A0 (FI)
Inventor: KESSLER MILTON
IPC: E06B7/22
Filed: 1985-09-17
Abstract: An improved pile-type, fin weatherstrip includes an elongated V- or U-shaped barrier fin bonded to a base strip and located between a pair of upstanding pile fiber arrays. The barrier fin is formed of thermoplastic film which is preferably smooth, but which may be roughened, dimpled or otherwise provided with a large number of pockets, or which may have a flocked surface. A lubricant grease is provided in the channel shaped cavity of the barrier fin, which lubricant is progressively dispensed in response to a wiping action type of movement which occurs when the barrier fin is compressed by the pile arrays during usage. The lubricant grease is exuded progressively over the useful life of the weatherstrip toward the free edges of the barrier fin located at or near the forward projecting face of the weatherstrip where such grease is dispensed in small amounts to decrease breakaway force, lower sliding friction and improved air infiltration characteristics. The barrier fin may be perforated so that lubricant grease is also forced into the fibers of the pile arrays where it will also work to the surface of the weatherstrip and improve the aforementioned properties.
Patent FI-864947-A0 (FI)
Inventor: ORCHARD OWEN JULIAN
IPC: B65H59/38
Filed: 1986-12-03
Abstract: The apparatus comprises a three phase induction motor (1) for turning the drum or spool (4) modified to have a high resistance rotor providing a torque speed characteristic of falling torque with increasing speed. The motor drive, and torque in either forward or reverse drive, is controlled by a pair of thyristor banks (14;15) selectively triggered for forward and reverse drive modes by error signals representative of variation in tension from the required value.
Patent FI-871369-A0 (FI)
Inventor: BOWMAN RICHARD P
IPC: B41M5/124
Filed: 1987-03-27
Abstract: A process for manufacturing microcapsules comprises in situ polymerization of a urea or melamine formaldehyde polymer precursor material in an aqueous manufacturing vehicle in the presence of one of a range of specified acrylic acid-alkyl methacrylate copolymers containing a critical proportion of alkyl methacrylate. The resulting capsules may be used in pressure-sensitive copying materials.
Patent FI-872754-A0 (FI)
Inventor: GREIG WALTER G
IPC: A63F3/06
Filed: 1987-06-22
Abstract: Each unit of the stock for a match-the-hidden-indicia game includes a base sheet (12) printed on one face (14) with a visually ascertainable pattern of indicia (16), and a cover sheet (22) also printed on one face (25) with a visually ascertainable pattern of indicia (26), which may or may not match the pattern on the base sheet. The one face of the base sheet on at least a band including the pattern of indicia, is provided with a transparent coating of permanent adhesive (18), and a liner layer (20) is facially adhered thereto. The relative attraction of the permanent adhesive for the one surface of the base sheet and the liner layer is such that any attempt to remove the liner layer will substantially disrupt the one surface, thus giving evidence of an attempt to tamper with the pattern of indicia on the base sheet. The cover sheet (22) is temporarily facially bonded to the liner layer to base sheet (12) in such a way as to obscure the pattern of indicia on the base sheet from view until the temporary bonding (24) of the cover sheet to the liner layer is disrupted, e.g. by peeling or tearing it away.
Patent FI-872962-A0 (FI)
Inventor: SCHREUDER JOHANNES CAROLUS PET
IPC: A61K8/44
Filed: 1987-07-03
Abstract: Skin tanning composition, comprising at least the following ingredients: - an oil fraction, comprising straight or branched paraffinic oils, having 10-30 carbon atoms in the chain and preferably 15-25 carbon atoms,  - an emulsifying systen, mainly comprising:   a) mono and/or diglycerides of higher unsaturated and/or saturated natural fatty acids, and b) ethoxylated glycerides, esterified with fatty acids, whereby the ratio between the amount of mono and/or diglycerides on the one hand and of the ethoxylated triglycerides on the other hand may vary from 10-100 parts mono and/or diglycerides pro part ethoxylated triglycerides, - panthenol and more preferably D-panthenol, and tyrosine and more preferably L-tyrosine, or a compound from which tyrosine may be easily formed in situ in the aqueous phase, the pH of which has to be in the range from 4-7, in a mutual molar ratio of tyrosine : panthenol between 2:1 and 1:3, - alkali to adjust the pH of the aqueous phase to be in the range from 4-7, e.g. in the form of sodium citrate and/or sodium hydroxide. - a stabilizer, consisting of montmorillonites, the free oxygen sites of which are occupied by quaternary groups, - a preservative, being the same or different for the formed contineous oily phase and the dispersed aqueous phase, - water ad 100 % by weight.
Patent FI-881369-A0 (FI)
Inventor: BOURSON LUCIEN
IPC: D21H17/00
Filed: 1988-03-22
Abstract: Papermaking process characterised in that the following are added to the suspension containing the cellulose fibres before the sheet is formed: calcium carbonate, a sizing agent such as a dimeric alkylketene or a carboxylic acid anhydride, cationic starch and a basic aluminium polychlorosulphate.
Patent FI-896279-A0 (FI)
Inventor: VERTESY LASZLO
IPC: C07K14/62
Filed: 1989-12-27
Abstract: Insulin derivatives with a basic modification owing to the basic amino acid arginine in position A0 of the formula II <IMAGE>  in which  a) R<3><0> + R<3><1> together = OH or b) R<3><0> = residue of a neutral, genetically encodable L-amino acid and R<3><1> = OH or a physiologically acceptable organic group which is basic in nature and has up to 50 C atoms, in whose structure 0 to 3  alpha -amino acids are involved and whose terminal carboxyl group, which is present where appropriate, can be free, as ester function, as amide function, as lactone or reduced to CH2OH, with the exception of the case in which, at the same time, R<3><0> = Ala, R<3><1> = OH and the A and B chain are the sequences of bovine insulin, and the physiologically tolerated salts thereof are obtained by various processes. The compounds are suitable for the treatment of diabetes mellitus, have a delayed profile of action and are very well tolerated.
Patent FI-901009-A0 (FI)
Inventor: CRAWLEY GRAHAM CHARLES
IPC: C07D239/74
Filed: 1990-02-28
Abstract: The invention concerns a heterocyclic cycloalkane of the formula I   <CHEM> wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene;  X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R<1> is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R<2> and R<3> together form a (3-6C)alkylene group which, together with the carbon atom to which R<2> and R<3> are attached, defines a ring having 4 to 7 ring atoms, and which ring may bear one or two substituents;  or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
Patent FI-915149-A0 (FI)
Inventor: CASTELLINO FRANCIS J
IPC: C12N15/12
Filed: 1991-10-31
Abstract: Recombinant human plasminogen may be produced in invertebrate cells or in other eukaryotic cells lacking a site-specific plasminogen activator by expression of a vector including a gene encoding human plasminogen. Human plasminogen may thus be expressed without degradation by plasmin produced by intracellular plasminogen activators found in mammalian cells. The plasminogen product of such expression may be purified, acylated, complexed with acylated or non-acylated fibrinolytic enzymes and formulated into pharmaceutical compositions for use in thrombolytic therapy.
Patent FI-933435-A0 (FI)
Inventor: HERBRECTHSMEIER PETER
IPC: G02C7/04
Filed: 1993-08-02
Abstract: The present invention relates to a contact lens which contains a crosslinked cyclodextrin derivative which has been rendered lipophilic and which is characterised by repeating units of the formula V <IMAGE> in which n is a number from 6 to 15, each of the R<1> radicals is, independently of the others, R<2> or R<7>, where at least one R<1> radical of the (3 times n) R<1> radicals has the meaning of R<7> and the remaining R<1> radicals are hydrogen or have the meaning of R<2>, in which R<2> is unsubstituted or halogen-substituted alkyl or alkyl-substituted aryl, and in which R<7> is a divalent or polyvalent radical of the formula VI <IMAGE> in which x is a number from 1 to 10,000, R<4>, R<5> and R<8> are, independently of one another, hydrogen, alkyl, unsubstituted or halogen-substituted alkylene or alkenylene, phenyl or hydroxyl, with the proviso that in one radical of the formula VI at least two of the radicals R<4>, R<5> and R<8> are unsubstituted or halogen-substituted alkylene or alkenylene. The invention likewise relates to the use of such crosslinked lipophilic cyclodextrin derivatives for producing contact lenses.
Patent FI-933666-A0 (FI)
Inventor: TUURNA SAMI
IPC: A63C5/11
Filed: 1993-08-20
Abstract: PCT No. PCT/FI94/00361 Sec. 371 Date Feb. 20, 1996 Sec. 102(e) Date Feb. 20, 1996 PCT Filed Aug. 19, 1994 PCT Pub. No. WO95/05973 PCT Pub. Date Mar. 2, 1995A handheld wing sail comprises a sailcloth supported on frame members. The frame members comprise two mast tubes positioned in a V shape defining a nose angle and opposite respective tips. A boom is located between the mast tubes, the boom being curved at the symmetry plane of the wing sail and connected to each mast tube by each supporting tubes, each fastened to the boom at one end by a connection member and fastened at the opposite end to the respective mast tubes. A traverse tube joins the mast tubes together and is fastened to the mast tubes by connection pieces. The mast tubes and the boom are connected to each other by a nose link, which comprises a threadlike connection member made of flexible but substantially non-stretchable material for making it possible to change the nose angle and to fold the mast tubes toward the boom, whereby to bring the wing sail into a folded position for turning the mast tubes and the boom freely in different directions when the wing sail is in the folded position and, thus, ready for transport. The tips of the mast tubes are at tips of the sailcloth and have flexible antenna portions for keeping the wing sail taut during sailing.
Patent FI-944162-A0 (FI)
Inventor: TSE HING CHEUNG
IPC: A23L1/308
Filed: 1994-09-09
Abstract: Psyllium-containing drink mix compositions comprising acid and base at a level whereby the composition, when combined with water, has a pH of greater than about 4.8.
Patent FI-953919-A0 (FI)
Inventor: DORIA GIANFEDERICO
IPC: C07D207/44
Filed: 1995-08-21
Abstract: New and known 5-Ä(2H-pyrrol-2-ylidene)methylÜ-2,2'-bi-1H-pyrrole derivatives, having immunomodulating activity and, represented by the following general formula (I) <CHEM> wherein, subject to a proviso, R1 represents hydrogen, phenyl, C1-C20 alkyl or C2-C20 alkenyl, wherein the alkyl and alkenyl groups may be unsubstituted or substituted by 1 to 3 substituents chosen independently from halogen, C1-C6 alkoxy, hydroxy, aryl and aryloxy; R2 represents hydrogen, C1-C6 alkyl, cyano, carboxy or (C1-C6 alkoxy) carbonyl; R3 represents halogen, hydroxy or C1-C11 alkoxy unsubstituted or substituted by phenyl; R4 represent hydrogen, C1-C6 alkyl or phenyl; each or R5 and R6 independently represents hydrogen, C2-C20 alkanoyl, C3-C20 alkenoyl, phenyl, C1-C20 alkyl or C2-C20 alkenyl, wherein the alkanoyl, alkenoyl, alkyl and the alkenyl groups may be unsubstituted or substituted by 1 to 3 substituents chosen independently from halogen, C1-C6 alkoxy, hydroxy, aryl, aryloxy, cyano, carboxy, (C1-C6 alkoxy)carbonyl, (C3-C4 alkenyl)carbamoyl, aralkylcarbamoyl, arylcarbamoyl and -CONRcRd in which each of Rc and Rd independently is hydrogen or C1-C6 alkyl or Rc arid Rd, taken together with the nitrogen atom to which they are linked, form a morpholino or piperidino ring; or two of R4, R5 and R6 taken together form a C4-C12 polymethylene chain, which can be unsubstituted or substituted by a C1-C12 alkyl, by a C2-C12 alkenyl or by a C1-C12 alkylidene group, wherein the alkyl, alkenyl and alkylidene groups may be in turn unsubstituted or substituted by a substituent chosen from halogen, C1-C6 alkoxy, hydroxy, cyano, carboxy, (C1-C6 alkoxy)carbonyl, aryloxy and aryl; the remaining one being hydrogen or C1-C12 alkyl; and the pharmaceutically acceptable salts thereof, are disclosed.
Patent FI-972353-A0 (FI)
Inventor: KOUTONEN PAULI
IPC: B65H18/26
Filed: 1997-06-03
Abstract: The invention concerns a method in winding of a web in a centre-drive winder, wherein the roll that is being formed is loaded and/or supported by means of a rider roll unit (40) whose position can be varied and which consists of at least two rolls (42). In the method, the force that is applied by the rider roll unit (40) to the roll face in the radial direction and/or the distribution of said force between the rolls (42) in the rider roll unit (40) is/are measured by means of a detector of detectors (31 . . . 36) directly connected with the winding head of the rider roll unit (40). The nip force of the rolls (42) in the rider roll unit (40) and/or the distribution of said nip force is/are regulated on the basis of the measurement signal given by the detectors.
Patent FI-973246-A0 (FI)
Inventor: TAKEMURA MAKOTO
IPC: C07D401/04
Filed: 1997-08-06
Abstract: The present invention provides an antibacterial compound useful as medicines, animal drugs, fisheries drugs or antibacterial preservatives and to an antibacterial agent or preparation which contains the same, more particularly a compound which possesses high safety and excellent activity against a broad range of bacterial species including quinolone-resistant strains. A quinolone derivative of the following formula (I) which has a group derived from the heterocyclic spiro-compound at the 7-positioned R<2> and the halogenocyclopropyl group at the N1-position, prefereably a compound of pure isomer, and an antibacterial agent containing the derivative compound. <CHEM>
Patent IL-66446-A0 (IL)
Title: Process and intermediates for production of benzothiazine carboxamides
IPC: C07G99/00
Filed: 1982-08-02
Abstract: A novel compound of empirical formula  C9H7N2O5SRR<1>Z (I)  produced by reacting an ester of the formula <CHEM> with an equimolar amount of an amine of the formula ZNH2 in a reaction inert organic solvent at a temperature of from about 0 to 110 DEG C wherein R is hydrogen benzyl or (C1-C3) alkyl; R<1> is benzyl or (C1-C4) alkyl and Z is benzopyronyl, alkyl substituted benzopyronyl, 2-pyridyl, alkyl substituted-2-pyridyl, 2-thiazolyl, 2-thiazolyl substituted by one or two alkyl group, or 5-alkyl-3-isoxazolyl, each alkyl having from one to four carbon atoms; and a novel process utilizing the compounds of formula (I) as intermediates for production of known anti-inflammatory agents of the formula <CHEM> u
Patent IL-74670-A0 (IL)
Title: Treatment of zircon
IPC: C01G25/02
Filed: 1985-03-20
Abstract: A process for treatment of zircon which comprises passing zircon particles of average dimensions between 50 and 1000 microns through a reactor and heating the particles up to a temperature above the melting point of silica but below the melting point of zirconia and wherein the particles pass through the reactor as discrete particles and wherein the residence time in the reactor is less than 10 sec.
Patent IL-78691-A0 (IL)
Title: Quinolylglycinamide derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D401/12
Filed: 1986-05-05
Abstract: The present invention relates to new quinolylglycinamide derivatives corresponding to the following general formula:    <IMAGE>  (I)  The invention also relates to a process for preparing these compounds and their therapeutic application as a psychotropic agent.
Patent IL-92103-A0 (IL)
Title: 3beta,17beta-hydroxy-substituted steroids,related steroidal compounds and pharmaceutical compositions containing them
IPC: A61P43/00
Filed: 1989-10-24
Abstract: The present invention is directed to a group of compounds which are 3 beta ,17 beta -hydroxy steroids, and related steroidal structures. These compounds are aromatase inhibitors, and thus, regulate or inhibit the conversion of androgens to estrogens. These compounds may be utilized to treat conditions potentiated by the presence of estrogens. These compounds exhibit a slower onset of action and a longer half life relative to the 10-(2-alkynyl) steroidal aromatase inhibitors disclosed in U.S. Patent 4,322,416.
Patent IL-97453-A0 (IL)
Title: Polymeric protective articles and electrical,optical or fluid-conduit apparatus incorporating such articles
IPC: F16L47/22
Filed: 1991-03-06
Abstract: Polymer latex coatings used as adhesives in heat-recoverable and/or high-voltage protective articles where latex adhesives not previously considered useful. Acrylic latexes are unexpectedly acceptable in high-voltage applications, and vinyl acetate/ethylene copolymers and terpolymer latexes are especially useful on polyolefin-based heat-recoverable articles. The latex coatings are substantially free from curing additives and are preferably non-curing, although latexes of inherently curable polymers may be used.
Patent FI-20002491-A0 (FI)
Inventor: MONONEN RISTO
IPC: H04L29/08
Filed: 2000-11-14
Abstract: The invention relates to a method and packet network for transmitting a packet from a source to a destination on the basis of an IP header in a packet network employing an IP protocol. The packet network comprises a first means arranged to drop at least a part of a destination address included in the IP header to a lower protocol layer to serve as a label. In addition, the packet network comprises a second means arranged to transmit the packet to the destination indicated by the label.
Patent FI-20010386-A0 (FI)
Inventor: VILJANMAA MIKA
IPC: F16C13/00
Filed: 2001-02-27
Abstract: The invention relates to a method for adjusting the properties of the polymer coating ( 2 ) of a roll or a belt ( 3 ), whereby the roll or the belt is used for calendering a fibrous web ( 4 ) in a roll nip (N), which is formed between the roll or the belt and its backing roll ( 5 ), whereby the roll or the belt has a polymer coating comprising fibrous material ( 1 ). In the method, the thermal elongation coefficient and/or thermal conductivity of the polymer coating ( 2 ) are adjusted by directing the fibre direction of the fibrous material ( 1 ).
Patent IL-103397-A0 (IL)
Title: Electronic monetary system
IPC: G07F7/10
Filed: 1992-10-09
Abstract: An improved monetary system using electronic media to exchange economic value securely and reliably. The invention provides a complete monetary system having electronic money that is interchangeable with conventional paper money comprising (1) issuing banks or financial institutions that are coupled to a money generator device for generating and issuing to subscribing customers electronic currency backed by demand deposits electronic credit authorizations; (2) correspondent banks that accept and distribute the electronic money; (3) a plurality of transaction devices that are used by subscribers for storing electronic money, for performing money transactions with the on-line systems of the participating banks or for exchanging electronic money with other like transaction devices; (4) automated teller devices, associated with the issuing and correspondent banks, for process handling and interfacing the transaction devices to the issuing and correspondent banks, and for interfacing between the issuing and correspondent banks themselves; and (5) a clearing bank for balancing the electronic money accounts of the different issuing banks (6).
Patent IL-106112-A0 (IL)
Title: Isolation and characterization of the growth hormone releasing hormone receptor
IPC: C07K14/72
Filed: 1993-06-23
Abstract: A method for identifying ligands that specifically bind to growth hormone releasing hormone receptor comprising:  a) labeing the ligand; b) incubating the labeled ligand with memebrane pellets comprising the growth hormone releasing hormone receptor; c) measuring total bound ligand; d) incubating the labeled ligand with membrane pellets comprising the growth hormone releasing hormone receptor in the presence of unlabeled ligand; e) measuring total bound ligand; and f) determining specific binding.
Patent IL-107337-A0 (IL)
Title: Ultrasoft embolism producing device
IPC: A61M25/095
Filed: 1993-10-20
Abstract: This invention is a flexible, vaso-occlusive device. The device may be a chain (600) or a platinum braid (200) having an outside diameter less than about 0.010 inches. The device is sufficiently flexible and small that it may be hydraulically delivered to a site within the vasculature of the human body using an injected drug or fluid flush through a catheter (512). <IMAGE>